{
    "code": "72000032",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=72000032",
    "time": "2023-05-05 05:54:24",
    "許可證字號": "衛部罕菌疫輸字第000032號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "119\/09\/21",
    "發證\/登錄日期": "109\/09\/21",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA07200003204",
    "中文品名": "磷平 30毫克注射液",
    "英文品名": "CRYSVITA 30mg solution for injection",
    "適應症": "性聯遺傳型低磷酸鹽症(X-linked hypophosphatemia，XLH)：適用於1歲以上兒童與青少年，及合併有XLH相關骨骼疾病之成人。",
    "劑型": "27D注射液劑",
    "包裝": "每盒100支以下，5毫升玻璃小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分",
    "監視期限": "114\/09\/21",
    "主成分略述": "burosumab",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣協和麒麟股份有限公司",
    "申請商地址": "台北市中山區中山北路二段68號9樓",
    "主製造廠": [
        {
            "製造廠名稱": "KYOWA KIRIN CO., LTD. TAKASAKI PLANT",
            "製造廠廠址": "100-1 HAGIWARA-MACHI, TAKASAKISHI, GUNMAN, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "原料藥及成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "PIRAMAL HEALTHCARE UK LIMITED",
            "製造廠廠址": "WHALTON ROAD, MORPETH, NORTHUMBERLAND, NE61 3YA, UK",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "ZUELLIG PHARMA SPECIALTY SOLUTIONS GROUP PTE. LTD.",
            "製造廠廠址": "15 CHANGI NORTH WAY #01-02, #02-02, #02-10, SINGAPORE 498770",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8405001000",
            "成分名稱": "burosumab",
            "含量描述": "",
            "含量": "30.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "[藥物外觀圖檔] Crysvita 30mg_2021OCT-110-10-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000032&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "[外盒圖檔] Crysvita 30mg_2021OCT-110-10-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000032&Seq=003&Type=8"
        },
        {
            "title": "CRYSVITA_標籤_30mg-109-12-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000032&Seq=002&Type=8"
        },
        {
            "title": "CRYSVITA_盒_30mg-109-12-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000032&Seq=001&Type=8"
        }
    ]
}